Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/000623 stock hub

SHE/000623 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/000623is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

22B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/000623

In the news

Latest news · SHE/000623

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E8

P25 23.5P50 41.3P75 83.2

ROE8.8

P25 -0.9P50 4.1P75 8.8

ROIC-0.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/000623 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

CNY

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	5,461
Employees Change	-284%
Employees Change Percent	-4.94
Enterprise value	CNY 21.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000000719
Last refreshed	2026-05-10
Market cap	CNY 22B
Price	CNY 18.79
Price currency	CNY
Rev Per Employee	407,738.91x
Sector	Healthcare
Sic	2834
Symbol	she/000623
Website	https://www.jlaod.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.46%
EV Earnings	7.87x
EV/FCF	188.71x
EV/Sales	9.7x
FCF yield	0.52%
P/B ratio	0.69x
P/E ratio	8.03x
P/S ratio	9.89x
PE Ratio10 Y	12.73x
PE Ratio3 Y	11.16x
PE Ratio5 Y	11.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.65%
EBITDA Margin	1.75%
FCF margin	5.14%
Gross margin	45.81%
Gross Profit	CNY 1B
Gross Profit Growth	5.21%
Gross Profit Growth Q	-15.15%
Gross Profit Growth3 Y	-11.81%
Gross Profit Growth5 Y	-4.95%
Net Income	CNY 2.7B
Net Income Growth	42.6%
Net Income Growth Q	67.56%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	7.53%
Net Income Growth5 Y	9.14%
Pretax Margin	123.82%
Profit Margin	123.25%
Profit Per Employee	CNY 502,545
Profitable Years	31
ROA	-0.27
Roa5y	-0.01
ROCE	-0.45
ROE	8.83
Roe5y	6.57
ROIC	-0.48
Roic5y	-0.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.58%
Cagr15y	1.95%
Cagr1y	19.74%
Cagr20y	12.38%
Cagr3y	6.03%
Cagr5y	7.22%
Div CAGR10	12.51%
Div CAGR3	18.56%
Div CAGR5	20.11%
EPS Growth	44.72
EPS Growth Q	68.04
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	9.78
EPS Growth5 Y	9.67
FCF Growth3 Y	47.82%
FCF Growth5 Y	35.19%
OCF Growth	77.11%
OCF Growth Q	-80.87%
OCF Growth10 Y	-4.86%
OCF Growth3 Y	-8.77%
OCF Growth5 Y	-5.15%
Revenue Growth	-6.12x
Revenue Growth Q	-17.43x
Revenue Growth Years	0x
Revenue Growth3 Y	-9.65x
Revenue Growth5 Y	-0.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.06
Assets	CNY 35.3B
Cash	CNY 2.9B
Current Assets	CNY 4.9B
Current Liabilities	CNY 2B
Debt	CNY 2.2B
Debt EBITDA	CNY 36.69
Debt Equity	CNY 0.07
Debt FCF	CNY 19.65
Equity	CNY 31.7B
Interest Coverage	-2.41
Liabilities	CNY 3.6B
Long Term Assets	CNY 30.4B
Long Term Liabilities	CNY 1.5B
Net Cash	CNY 648M
Net Cash By Market Cap	CNY 2.94
Net Cash Growth	137.88%
Net Debt EBITDA	CNY -16.65
Net Debt Equity	CNY -0.02
Net Debt FCF	CNY -5.66
Tangible Book Value	CNY 31.1B
Tangible Book Value Per Share	CNY 26.52
WACC	7.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.38
Inventory Turnover	1.41
Net Working Capital	CNY 864.2M
Quick ratio	1.94
Working Capital	CNY 2.8B
Working Capital Turnover	CNY 0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.47%
Dividend Growth	-37.5%
Dividend Growth Years	0%
Dividend per share	CNY 0.5
Dividend Years	17
Dividend Yield	2.66%
Last Dividend	CNY 0.2
Payout Frequency	Semi-Annual
Payout Ratio	23.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	16.98%
1Y total return	19.72%
200-day SMA	19.34
3Y total return	19.22%
50-day SMA	18.24
50-day SMA vs 200-day SMA	50under200
5Y total return	41.68%
All Time High	45.86
All Time High Change	-59.03%
All Time High Date	2007-10-19
All Time Low	0.98
All Time Low Change	1,814.03%
All Time Low Date	2002-01-21
ATR	0.37
Beta	0.61
Beta1y	0.49
Beta2y	0.65
Ch YTD	-3.79
High	18.96
High52	22.08
High52 Date	2025-10-29
High52ch	-14.9%
Low	18.73
Low52	16.04
Low52 Date	2025-05-08
Low52ch	17.15%
Ma50ch	3.04%
Price vs 200-day SMA	-2.86%
RSI	58.82
RSI Monthly	53.6
RSI Weekly	50.19
Sharpe ratio	0.77x
Sortino ratio	1.37
Total Return	4.13%
Tr YTD	-3.79
Tr15y	33.58%
Tr1m	7.19%
Tr1w	-1.11%
Tr3m	-0.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY -148.1M
Operating Income Growth Q	285.9
Operating margin	-6.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	807,296,768%
Net Borrowing	-149,359,429
Shares Insiders	0.55%
Shares Institutions	9.96%
Shares Out	1,172,381,587
Shares Qo Q	0%
Shares Yo Y	-1.47%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 114.5M
Average Volume	11,851,306.9x
Bv Per Share	26.86
CAPEX	CNY -112.6M
Ch10y	-4.17
Ch15y	6.44
Ch1m	7.19
Ch1w	-1.11
Ch1y	16.49
Ch20y	712.4
Ch3m	-0.69
Ch3y	7.49
Ch5y	23.62
Ch6m	-11.2
Change	-0.63%
Change From Open	-0.37
Close	18.91
Days Gap	-0.26
Depreciation Amortization	187,075,089
Dollar Volume	211,677,410.9
Earnings Date	2026-04-18
EBIT	CNY -148.1M
EBITDA	CNY 38.9M
EPS	CNY 2.34
F Score	4
FCF	CNY 114.5M
FCF EV Yield	0.53x
FCF Per Share	CNY 0.1
Financing CF	-800,184,462
Fiscal Year End	December
Founded	1,957
Graham Number	37.61419
Graham Upside	100.2
Income Tax	CNY 47.1M
Investing CF	642,058,144
Is Primary Listing	1
Last Earnings Date	2026-04-18
Last Report Date	2026-03-31
Last Split Date	2017-06-19
Last Split Type	Forward
Lynch Fair Value	CNY 21.4
Lynch Upside	13.9
Ma150	19.38
Ma150ch	-3.05%
Ma20	18.29
Ma20ch	2.76%
Net CF	68,476,953
Next Earnings Date	2026-08-28
Open	18.86
P FCF Ratio	192.5
P OCF Ratio	97.04
Payment Date	2025-10-22
Position In Range	26.09
Ppne	2,331,441,322
Price Date	2026-05-08
Price EBITDA	CNY 566
Ptbv Ratio	0.71
Relative Volume	0.97x
Revenue	2,226,662,187x
Tax By Revenue	2.12x
Tax Rate	1.71%
Tr20y	932.93%
Tr6m	-11.2%
Volume	11,265,429
Z Score	4.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/000623 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$0.50 annual per share

Payout ratio

+23.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.1%

0 consecutive years of growth

Total shareholder yield

+4.1%

Dividend yield + buyback yield combined

Performance

SHE/000623 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/000623?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.0%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.5%

Negative means the company is buying back shares.

Technical

SHE/000623 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.8

Neutral momentum band

Price vs 200-day MA

-2.9%

50/200-day relationship not available

Beta (5Y)

0.61

Less volatile than the market

Sharpe ratio

0.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/000623

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/000623 stock rating?

she/000623 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/000623 analysis?

The full report lives at /stocks/she/000623/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/000623?

The latest report frames she/000623 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/000623 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.